Molecular Imaging: Page 88

Theragnostics enters licensing deal with AAA for Ga-68 PET

By AuntMinnie.com staff writers

Theragnostics has signed a global licensing agreement with Advanced Accelerator Applications (AAA) to develop and commercialize gallium-68 (Ga-68) one-step PET radiopharmaceuticals.

September 21, 2021

SNMMI updates appropriate use criteria for PSMA PET

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released new guidance for the clinical use of prostate-specific membrane antigen (PSMA)-PET imaging.

September 20, 2021

PET detects activity in early atherosclerosis

By Will Morton

PET imaging has shown that an experimental radiotracer can detect cellular activity in the artery walls of patients with atherosclerosis, according to a study published September 18 in the Journal of Nuclear Medicine.

September 20, 2021

PET identifies 'tipping point' for patients with Alzheimer's

By AuntMinnie.com staff writers

The age of symptom onset in people with sporadic Alzheimer's disease is strongly correlated with the age at which individuals reach a tipping point in amyloid accumulation, according to a new study.

September 16, 2021

Telix applauds NCCN radiotracer update

By AuntMinnie.com staff writers

Injection kit developer Telix applauded the National Comprehensive Cancer Network's (NCCN) decision to update its guidelines on prostate-specific membrane antigen PET imaging in prostate cancer testing.

September 15, 2021

BWXT and Bayer to focus on therapeutic radionuclides

By AuntMinnie.com staff writers

BWXT Medical and Bayer have entered an agreement to ramp up their supply of actinium-225 as both companies seek to broaden commercialization strategies for targeted radionuclide therapies.

September 15, 2021

Radialis seeks FDA clearance for new PET camera

By AuntMinnie.com staff writers

Radialis Medical has applied for U.S. Food and Drug Administration (FDA) 510(k) clearance for its Radialis PET camera for organ-based imaging.

September 15, 2021

Cardiac PET predicts outcomes in aortic stenosis

By Will Morton

PET imaging has shown how impaired blood flow in small vessels of the heart may lead to myocardial stress and injury in patients with aortic stenosis, according to a study published online September 15 in JAMA Cardiology.

September 15, 2021

IBA, SCK CEN sign actinium-225 deal

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) and Belgian nuclear research center SCK CEN have partnered to enable the production of the medical radioisotope actinium-225.

September 14, 2021

Pylarify added to NCCN prostate cancer guidelines

By AuntMinnie.com staff writers

Lantheus Medical Imaging's PET radiotracer Pylarify (F-18 piflufolastat) has been included in the National Comprehensive Cancer Network (NCCN) guidelines for imaging prostate cancer.

September 13, 2021

PET tracer predicts response to immunotherapy

By Will Morton

An experimental PET radiotracer can predict whether patients will respond early to new immunotherapy treatments for metastatic skin cancer, according to a study published September 9 in the Journal of Nuclear Medicine.

September 13, 2021

Lantheus, RefleXion to collaborate on prostate cancer treatment

By AuntMinnie.com staff writers

Lantheus Medical Imaging parent Lantheus Holdings and radiation therapy equipment developer RefleXion Medical have signed a development and marketing partnership to evaluate the use of Lantheus' prostate-specific membrane antigen-targeted PET agent piflufolastat F-18 with RefleXion's X1 biology-guided radiotherapy system.

September 12, 2021

Previous Page

Page 88 of 614

Next Page